Study of Lupus Vascular and Bone Longterm Endpoints
狼疮血管和骨骼长期终点研究
基本信息
- 批准号:7665020
- 负责人:
- 金额:$ 29.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Systemic lupus erythematosus (SLE) is the prototypic systemic inflammatory autoimmune disease that
affects predominantly young premenopausal women. As survival has improved over the last two decades,
increasing numbers of young women with SLE are experiencing cardiovascular (CVD) and osteoporotic (OP)
related complications typically associated with aging in non-SLE populations of women. The occurrence of
these complications remains increased, even after adjusting for known traditional risk factors and the use of
corticosteroids associated with these complications. Macrophages play a critical role in the initiation and
progression of atherosclerosis and monocytes or macrophages are precursors of osteoclasts, which
contribute to osteoporosis. Our preliminary data shows during the in vitro differentiation of normal monocytes
into macrophages there is upregulation of a large number of genes important for lipid metabolism and
transport, which promote the formation of foam cells. Moreover, there is upregulation of many genes
important for function of osteoclasts, even though these cells are not osteoclasts. The specific aims in this 5-
year longitudinal study with 180 SLE and 180 non-SLE subjects are 1) to followup study participants at three
years and five years after baseline assessment to determine the rate of progression of carotid, coronary, and
aortic atherosclerosis in SLE women compared to age- race- and geographically-similar non-SLE controls, 2)
examine lipid metabolism gene expression profiles in macrophages and relate these gene expression
profiles to clinical observations of subclinical CVD, and 3) examine gene expression profiles in macrophages
which are potentially important in osteoclast function and relate these gene expression profiles to previous
clinical observations of bone mineral density, BMD, measured at the lumbar spine and hip. The main goal of
this study is to test the hypothesis that the increased occurrence and progression of subclinical and CVD and
OP markers and events in SLE women are associated with differential gene expression profiles of selected
biological pathways or function in macrophages. Focusing on the macrophage as the key cell involved in the
pathophysiology of both CVD and OP and merging the new data on gene upregulation in macrophages with
a carefully and extensively defined phenotype, in a longitudinal cohort, should provide new insights into the
chronic inflammatory state that predisposes women with SLE to develop accelerated CVD and OP.
全身性红斑狼疮(SLE)是原型的全身性炎症自身免疫性疾病
影响年轻的年轻前女性。随着过去二十年来生存的提高,
越来越多的年轻女性患有心血管(CVD)和骨质疏松症(OP)
相关的并发症通常与非熟食女性衰老有关。出现
这些并发症仍然增加,即使调整了已知的传统风险因素并使用
与这些并发症相关的皮质类固醇。巨噬细胞在开始中起着至关重要的作用
动脉粥样硬化和单核细胞或巨噬细胞的进展是破骨细胞的前体
有助于骨质疏松症。我们的初步数据显示了正常单核细胞的体外分化
进入巨噬细胞,有大量对脂质代谢重要的基因上调
转运,促进泡沫细胞的形成。而且,许多基因都上调
即使这些细胞不是破骨细胞,对于破骨细胞的功能很重要。这5-的具体目的
使用180 SLE和180名非SLE受试者的年度纵向研究是1)跟进研究参与者
基线评估后的年和五年,以确定颈动脉,冠状动脉和
与年龄和地理位置相似的非SLE对照相比,SLE女性的主动脉动脉粥样硬化,2)
检查巨噬细胞中的脂质代谢基因表达谱并关联这些基因表达
对亚临床CVD的临床观察以及3)检查巨噬细胞中的基因表达谱图
在破骨细胞功能中可能很重要,并将这些基因表达谱与以前的
在腰椎和臀部测量的骨矿物质密度BMD的临床观察结果。主要目标
这项研究是为了检验以下假设:亚临床和CVD的发生和进展增加
SLE女性的OP标记和事件与选定的差异基因表达谱有关
巨噬细胞中的生物途径或功能。专注于巨噬细胞作为涉及的关键单元
CVD和OP的病理生理学以及合并有关巨噬细胞基因上调的新数据
在纵向队列中,精心且广泛定义的表型应提供对该表型的新见解
慢性炎症状态使患有SLE的妇女易于发展加速的CVD和OP。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Rosalind Ramsey-G...的其他基金
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
区分抗磷脂酰乙醇胺两种亚型的临床特征
- 批准号:1065405510654055
- 财政年份:2022
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
区分抗磷脂酰乙醇胺两种亚型的临床特征
- 批准号:1051039410510394
- 财政年份:2022
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Cancer risk after renal transplant in autoimmune disease
自身免疫性疾病肾移植后的癌症风险
- 批准号:83874028387402
- 财政年份:2012
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Cancer risk after renal transplant in autoimmune disease
自身免疫性疾病肾移植后的癌症风险
- 批准号:85071838507183
- 财政年份:2012
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Fatigue and Lifestyle Physical Activity in SLE
SLE 患者的疲劳和生活方式体力活动
- 批准号:81146078114607
- 财政年份:2011
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Fatigue and Lifestyle Physical Activity in SLE
SLE 患者的疲劳和生活方式体力活动
- 批准号:83185748318574
- 财政年份:2011
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Study of Lupus Vascular and Bone Longterm Endpoints
狼疮血管和骨骼长期终点研究
- 批准号:72672767267276
- 财政年份:2007
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
PREDICTORS OF PREGNANCY OUTCOMES IN SLE AND APS
SLE 和 APS 妊娠结局的预测因素
- 批准号:76043107604310
- 财政年份:2006
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
TRANSESOPHAGEAL ECHOCARDIOGRAPHY EVALUATION AND MRI OF THE AORTA IN LUPUS
狼疮主动脉的经食管超声心动图评估和 MRI
- 批准号:76043267604326
- 财政年份:2006
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
EPIDEMIOLOGY OF OSTEOPOROSIS IN WOMEN WITH LUPUS - MAMDC PROJECT
狼疮女性骨质疏松症的流行病学 - MAMDC 项目
- 批准号:76042357604235
- 财政年份:2006
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
相似国自然基金
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
- 批准号:82370796
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:82103851
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
自主要求剖宫产对子代工作记忆的影响及低位GCs与海马CRH-CRHR1信号互作机制
- 批准号:81872630
- 批准年份:2018
- 资助金额:58.0 万元
- 项目类别:面上项目
应用H295R细胞研究SF-1、ACTHR对肾上腺皮质激素分泌调控的影响机制
- 批准号:81200579
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:1060088710600887
- 财政年份:2023
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
关节内药物递送调节炎症性关节疾病中的免疫细胞
- 批准号:1085675310856753
- 财政年份:2023
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:1082033110820331
- 财政年份:2023
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Toward therapeutic targeting of liquid-liquid phase separation dynamics in skin
皮肤液-液相分离动力学的治疗靶向
- 批准号:1067961010679610
- 财政年份:2023
- 资助金额:$ 29.02万$ 29.02万
- 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:1064901210649012
- 财政年份:2023
- 资助金额:$ 29.02万$ 29.02万
- 项目类别: